X23-12-YM1141 |
VCE-004.8
|
|
X24-08-YM418 |
PPAR inhibitor, Fenofibrate, Purity ≥98%
|
|
X24-08-YM419 |
PPAR inhibitor, Gemfibrozil, Purity ≥98%
|
|
X24-08-YM420 |
PPAR inhibitor, 5-Aminosalicylic acid, Purity ≥98%
|
|
X24-08-YM421 |
PPAR inhibitor, Rosiglitazone, Purity ≥98%
|
|
X24-08-YM422 |
PPAR inhibitor, Rosiglitazone maleate, Purity ≥98%
|
|
X24-08-YM423 |
PPAR inhibitor, Cetaben, Purity ≥98%
|
|
X24-08-YM425 |
PPAR inhibitor, T0070907, Purity ≥98%
|
|
X24-08-YM426 |
PPAR inhibitor, Pioglitazone, Purity ≥98%
|
|
X24-08-YM427 |
PPAR inhibitor, Ciprofibrate, Purity ≥98%
|
|
X24-08-YM429 |
PPAR inhibitor, GW 7647, Purity ≥98%
|
|
X24-08-YM430 |
PPAR inhibitor, L-165,041, Purity ≥98%
|
|
X24-08-YM431 |
PPAR inhibitor, GW 9662, Purity ≥98%
|
|
X24-08-YM432 |
PPAR inhibitor, Pirinixic acid, Purity ≥98%
|
|
X24-08-YM433 |
PPAR inhibitor, GSK-3787, Purity ≥98%
|
|
X24-08-YM434 |
PPAR inhibitor, GSK 0660, Purity ≥98%
|
|
X24-08-YM435 |
PPAR inhibitor, GW6471, Purity ≥98%
|
|
X24-08-YM436 |
PPAR inhibitor, Aleglitazar, Purity ≥98%
|
|
X24-08-YM437 |
PPAR inhibitor, Chiglitazar, Purity ≥98%
|
|
X24-08-YM438 |
PPAR inhibitor, Pparδ agonist 2, Purity ≥98%
|
|